Management of Mild Alcohol Withdrawal

Dosing Regimen

For mild alcohol withdrawal symptoms, the American College of Gastroenterology recommends starting with chlordiazepoxide 25-50 mg orally every 6 hours for the first day 1, 2
For moderate symptoms, the American Association for the Study of Liver Diseases suggests starting with 50-100 mg orally every 6 hours 1, 2

The American Society of Addiction Medicine recommends using the Clinical Institute Withdrawal Assessment for Alcohol (CIWA-Ar) scale to assess withdrawal severity; scores >8 indicate moderate withdrawal and ≥15 indicate severe withdrawal 3
A symptom-triggered regimen is preferred over fixed-dose schedule to prevent medication accumulation, according to the European Association for the Study of the Liver 3
Regular monitoring of vital signs, mental status, and withdrawal symptoms is recommended by the American College of Physicians 4

The National Institute on Alcohol Abuse and Alcoholism suggests thiamine supplementation (100-300 mg/day) should be given to all patients with alcohol withdrawal syndrome to prevent Wernicke encephalopathy 2, 5
Administering thiamine before giving any glucose-containing fluids can help prevent precipitating acute thiamine deficiency, as recommended by the American Gastroenterological Association 2
For patients with liver dysfunction, advanced age, or respiratory issues, consider lorazepam (1-4 mg every 4-8 hours) instead of chlordiazepoxide, according to the American Association for the Study of Liver Diseases 5
Ensuring adequate hydration and electrolyte replacement, especially magnesium, is crucial, as recommended by the European Society of Gastrointestinal Endoscopy 2

Mild withdrawal can typically be managed in outpatient settings, according to the American Society of Addiction Medicine 6
Inpatient treatment should be considered for patients with a history of withdrawal seizures or delirium tremens, significant medical or psychiatric comorbidities, failed outpatient treatment, or high levels of recent drinking, as recommended by the American College of Emergency Physicians 2, 4, 6

Benzodiazepines are the gold standard for alcohol withdrawal treatment due to their efficacy in reducing symptoms and preventing seizures and delirium tremens, according to the American College of Gastroenterology 2, 3
Long-acting benzodiazepines like chlordiazepoxide provide more protection against seizures and delirium compared to short-acting ones, as recommended by the European Association for the Study of the Liver 3
Avoid using benzodiazepines beyond 10-14 days due to potential for abuse, according to the American Society of Addiction Medicine 3

Carbamazepine (200 mg every 6-8 hours) can be used as an alternative to benzodiazepines for seizure prevention, as suggested by the American Academy of Neurology 2
Haloperidol (0.5-5 mg every 8-12 hours) may be used carefully as adjunctive therapy only for agitation or psychotic symptoms not controlled by benzodiazepines, according to the American Psychiatric Association 2
Psychiatric consultation is recommended for evaluation, treatment, and long-term planning of alcohol abstinence, as recommended by the American Society of Addiction Medicine 2, 5

The American Association for the Study of Liver Diseases recommends benzodiazepines as the gold standard for alcohol withdrawal syndrome, but gabapentin can be used as an adjunctive or alternative agent for mild withdrawal and is particularly effective for alcohol dependence at 1800 mg/day in divided doses 7, 8

For patients with hepatic dysfunction, gabapentin does not require hepatic metabolism and may be preferred over benzodiazepines in advanced liver disease 7, 8
However, dose reduction is required for renal insufficiency based on creatinine clearance 9, 10
In elderly patients or those with respiratory compromise, gabapentin may be safer than long-acting benzodiazepines 7

Use CIWA-Ar scores to guide treatment: >8 indicates moderate withdrawal, ≥15 indicates severe withdrawal 7, 8
Symptom-triggered regimens are preferred over fixed-dose schedules to prevent medication accumulation 7, 8